<b>Background/Objectives:</b> Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are increasingly used for the management of obesity and type 2 diabetes, particularly among women of reproductive age. The gene discussed is GLP1R; the disease is obesity disorder.